3,000 tumor samples could unlock secrets of drug resistance
NCT ID NCT03572192
First seen Nov 18, 2025 · Last updated May 16, 2026 · Updated 29 times
Summary
This study collects leftover tissue and blood samples from 3,000 adults with solid tumors during routine care. Researchers will use advanced lab tests to find out why cancer cells spread and become resistant to treatments. The goal is to discover clues that could lead to better therapies and personalized treatment plans.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOURS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St Bartholomew's Hospital
RECRUITINGLondon, EC1A 7BE, United Kingdom
Contact
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.